The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases
R Ghani, BH Mullish, LA Roberts, FJ Davies… - Gut …, 2022 - Taylor & Francis
The intestinal microbiota is recognized to play a role in the defense against infection, but
conversely also acts as a reservoir for potentially pathogenic organisms. Disruption to the …
conversely also acts as a reservoir for potentially pathogenic organisms. Disruption to the …
Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian …
C Girmenia, A Bertaina, A Piciocchi… - Clinical Infectious …, 2017 - academic.oup.com
Background Gram-negative bacteremia (GNB) is a major cause of illness and death after
hematopoietic stem cell transplantation (HSCT), and updated epidemiological investigation …
hematopoietic stem cell transplantation (HSCT), and updated epidemiological investigation …
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
C Cattaneo, R Di Blasi, C Skert, A Candoni… - Annals of …, 2018 - Springer
Infections by multidrug-resistant (MDR) bacteria are a worrisome phenomenon in
hematological patients. Data on the incidence of MDR colonization and related bloodstream …
hematological patients. Data on the incidence of MDR colonization and related bloodstream …
[HTML][HTML] Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug …
G Battipaglia, F Malard, MT Rubio, A Ruggeri… - …, 2019 - ncbi.nlm.nih.gov
Fecal microbiota transplantation is an effective treatment in recurrent Clostridium difficile
infection. Promising results to eradicate multidrug-resistant bacteria have also been reported …
infection. Promising results to eradicate multidrug-resistant bacteria have also been reported …
[HTML][HTML] How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection
R Ghani, BH Mullish, FJ Davies, JR Marchesi - Clinical Microbiology and …, 2022 - Elsevier
Background Vulnerable patients with intestinal colonization of multidrug-resistant organisms
(MDROs) are recognized to be at increased risk of invasive MDRO-driven infection …
(MDROs) are recognized to be at increased risk of invasive MDRO-driven infection …
[HTML][HTML] Bloodstream infections in patients with hematologic diseases: causative organisms and factors associated with resistance
H Choi, H Ahn, R Lee, SY Cho… - Infection & Chemotherapy, 2022 - ncbi.nlm.nih.gov
Background Patients with hematologic diseases are at high risk of bloodstream infections
(BSIs). This study aimed to analyze clinical features and distributions of microorganisms in …
(BSIs). This study aimed to analyze clinical features and distributions of microorganisms in …
Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies
Infections and especially blood stream infections (BSI) with gram-negative bacteria (GNB)
represent a major threat for patients with hematological diseases undergoing chemotherapy …
represent a major threat for patients with hematological diseases undergoing chemotherapy …
Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol–a prospective nationwide study
A Kolonen, M Sinisalo, R Huttunen, J Syrjänen… - Infectious …, 2017 - Taylor & Francis
Background: Infections greatly influence the outcome of acute myeloid leukemia (AML)
patients receiving intensive treatment. The aim of this study was to establish the incidence …
patients receiving intensive treatment. The aim of this study was to establish the incidence …
Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
AS Danielsen, L Franconeri, S Page, AE Myhre… - BMC Infectious …, 2023 - Springer
Background Infections are major causes of disease in cancer patients and pose a major
obstacle to the success of cancer care. The global rise of antimicrobial resistance threatens …
obstacle to the success of cancer care. The global rise of antimicrobial resistance threatens …
Acute myeloid leukemia and the infectious diseases consultant
V Mulanovich, DP Kontoyiannis - Leukemia & lymphoma, 2018 - Taylor & Francis
Infectious complications following treatment of acute myeloid leukemia (AML) are important
causes of morbidity and mortality. The spectrum and complexity of these infections is …
causes of morbidity and mortality. The spectrum and complexity of these infections is …